CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parenthetical) $ in Thousands		3 Months Ended
	Nov. 03, 2023	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)
Direct patient expense		$ 45,865	$ 68,427
Selling, general and administrative expense		89,109	96,473
Interest expense		14,930	23,505
Reverse stock split ratio	0.01
Related Party
Direct patient expense		0	4,115
Selling, general and administrative expense		304	$ 1,327
Interest expense		$ 22,093